Cyclooxygenase Pathway

Diverse physical,
chemical, Glucocorticoids
Phospholipase A2
inflammatory, and
mitogenic stimuli

NSAIDS NSAIDS

Arachidonic Acid

Prostaglandin G2 CYCLOOXYGENASE Prostaglandin G2

Prostaglandin H Prostaglandin H
Synthase-1 Synthase-2
(cyclooxygenase 1) (cyclooxygenase 2)

Prostaglandin H2 PEROXIDASE Prostaglandin H2

Tissue Specific Isomerases

Prostacyclin Thromboxane A2 Prostaglandin D2 Prostaglandin E2 Prostaglandin F2α

P. 2 P. 3-4 P. 5-6 P. 7-9 P. 10-11

IP TPα, TPβ DP1, DP2 EP1, EP2, EP3, EP4 FPα, FPβ

Endothelium, Kidney, Platelets, Vascular Mast Cells, Brain, Brain, Kidney, Vascular Uterus, Airways, Vascular
Platelets, Brain Smooth Muscle Cells, Airways, Lymphocytes, Smooth Muscle Cells, Smooth Muscle Cells,
Macrophages, Kidney Eosinophils Platelets Eyes
Prostacyclin Product Name
(Item No.)
Sensitivity
Limit of detection
Recommended
Sample Matrices
Incubation
Time
Prostacyclin (Prostaglandin I2; PGI2) is formed from arachidonic acid
primarily in the vascular endothelium and renal cortex by sequential 6-keto Prostaglandin 50% B/B0: 40 pg/ml Urine, culture media 18 hours at 4°C
activities of cyclooxygenase and prostacyclin synthase. PGI2 is F1α EIA Kit (515211) 80% B/B0: 6 pg/ml
nonenzymatically hydrated to 6-keto PGF1α (t½=2-3 minutes), and then
quickly converted to the major metabolite, 2,3-dinor-6-keto PGF1α (t½=30
minutes). Prostacyclin was once thought to be a circulating hormone
that regulated platelet-vasculature interactions, but the rate of secretion
into circulation coupled with the short half-life indicate that prostacyclin
functions locally. Estimates of systemic PGI2 production have often been Prostacyclin Pathway Reagents
assessed by measurement of 6-keto PGF1α alone or in combination with
Synthase
2,3-dinor-6-keto PGF1α. However, the majority of 6-keto PGF1α in urine is Antibodies/Probes Agonists Antagonists
Inhibitor
of renal origin with only 14% originating from plasma.
COOH
IP receptor (human) Prostaglandin I2 CAY10441 U-51605
Polyclonal Antibody (sodium salt) 10005186 16465
Arachidonic Acid
10005518 18220
Cyclooxygenase AFP 07 (free acid) 13626
IP receptor (mouse) CAY10449
Polyclonal Antibody Beraprost (sodium salt) 10005913
PGH2
O COOH
160070 18230
O
Iloprost
OH PGIS 18215, 10008585
Prostacyclin Synthase
Polyclonal Antibody
160640 NS-304
10010411
PGIS Carbaprostacyclin
COO- Na+
Monoclonal Antibody 18210, 18212
O
160630
Ciprostene (calcium salt)
PGI2 PGIS Monoclonal 18216
HO Antibody (Clone 3C8) Treprostinil
OH
10247 10162
non-enzymatic MRE-269
OH
PGIS (mouse) 10010412
COOH
6-keto PGF1α Polyclonal Antibody Piriprost 18228
O
100023
HO Taprostene
OH
10011348
β-oxidation
OH

COO- Na+
2,3-dinor-6-keto PGF1α
O

HO
OH

Thromboxane A2
Thromboxane A2 (TXA2) is produced from arachidonic acid by many O COOH

cells and causes irreversible platelet aggregation and vascular and O

bronchial smooth muscle contraction. TXA2, like most lipid mediators, PGH2 OH

is not a circulating hormone. It is formed in response to local stimuli Thromboxane Synthase

and exerts its effects within a short distance of its biosynthesis. TXA2
is rapidly hydrolyzed non-enzymatically to form TXB2. Although it
is common to estimate TXA2 levels by measuring TXB2, most of the COOH
O
TXB2 measured is due to ex vivo platelet activation or intra-renal
production. Measurement errors are compounded by the fact that TXA2
OH

normal concentrations of circulating TXB2 are extremely low (1-2 pg/

Non-enzymatic
ml), and highly transient (t½= 5-7 minutes). To circumvent this problem,
it is necessary to measure a metabolite that cannot be formed by OH

platelets or by the kidney. TXB2 may be metabolized by 11-hydroxy COOH

TX dehydrogenase to form 11-dehydro TXB2, or by β-oxidation to

form 2,3-dinor TXB2. Infusion studies using TXB2 have shown that
HO O
OH

both metabolites are formed equally, although 11-dehydro TXB2 has TXB2
a longer circulating half-life (t½= 45 minutes). Therefore, measurement TBX2 11-dehydrogenase β-oxidation
of 11-dehydro TXB2 in plasma or urine will give a time-integrated
indication of TXA2 production. The circulating half-life of 2,3-dinor TXB2
is shorter (t½ = 15 minutes). Therefore, measurement of 2,3-dinor TXB2 OH OH

will give a more episodic indication of TXA2 production. COOH COOH

O

O HO O
OH OH

11-dehydro TXB2 2,3-dinor TXB2

2 Cayman Chemical • Ann Arbor, MI 48108 • 800.364.9897 • www.caymanchem.com

Thromboxane Pathway Reagents
Antibodies/Probes Agonists Antagonists Synthase Inhibitors
TP Receptor (human) Polyclonal FITC Antibody 10012559 Carbocyclic Thromboxane A219010 I-SAP 19021 Furegrelate (sodium salt) 70540
TP Receptor (human) Polyclonal Antibody 10004452 U-46619 16450, I-BOP 19600 BAY-u3405 10156 Ozagrel 70515
TP Receptor (murine) Polyclonal Antibody 101882 U-44069 16440 SQ 29,548 19025 1-Benzylimidazole 70510
TXB2 11-dehydrogenase Polyclonal Antiserum 160720 GW 627368X 10009162 BM 567 10155
Thromboxane Synthase Polyclonal Antibody 160715 BM 567 10155 15(R)-Pinane Thromboxane A210008510
CAY10535 10010396
AH 23848 (calcium salt) 19023
L-655,240 10011562

Product Name (Item No.) Sensitivity · Limit of Detection Incubation Time

Thromboxane B2 EIA Kit (501020) 50% B/B0: 60 pg/ml • 80% B/B0: 5 pg/ml 18 hours at room temperature

Thromboxane B2 Express EIA Kit - Monoclonal (10004023) 50% B/B0: 176 pg/ml • 80% B/B0: 45 pg/ml 2 hours at room temperature

11-dehydro Thromboxane B2 EIA Kit - Monoclonal (519510) 50% B/B0: 120 pg/ml • 80% B/B0: 34 pg/ml 2 hours at room temperature

Recommendation for which Thromboxane B2 Assay to choose

Sample Type TXB2 Kit (501020) TXB2 Express EIA Kit - Monoclonal 11-dehydro TXB2 EIA Kit (519510)
(10004023)
Plasma
X X Levels may be the limit of detection of this kit

Serum
  X
TXB2 will primarily be found ex vivo TXB2 will primarily be found ex vivo
Urine Application dependent - a potion of urinary Application dependent - a potion of urinary
TXB2 may be of renal origin TXB2 may be of renal origin 
Cell culture Caution: FBS contains high quantities of Caution: FBS contains high quantities of
TXB2 TXB2 X
In vitro COX-1 reactions
  X
CSF Levels may be below the limit of detection
X X of this kit
Notes Most sensitive, overnight incubation 2 hr incubation ~4.5-fold less sensitive than Detects the 11-dehydro metabolite of TXB2
TXB2 EIA Kit

X Not recommended recommended matrix

Prostaglandin D2 Product Name

(Item No.)
Sensitivity
Limit of Detection
Incubation Time

Prostaglandin D2 EIA Kit (512031) 50% B/B0: 240 pg/ml Overnight at 4°C
Prostaglandin D2 (PGD2) is biosynthesized in 80% B/B0: 55 pg/ml
the brain by a soluble, 26 kDa glutathione- O COOH

independent lipocalin-type PGD2 synthase. O

Prostaglandin D2 Express EIA Kit (512041) 50% B/B0: 1,300 pg/ml 2 hours at room
This PGD2 accumulates in the cerebrospinal PGH2 OH

fluid (CSF), where it induces physiologic 80% B/B0: 350 pg/ml temperature
sleep in rats and humans. PGD2 is also PGD Synthase
synthesized in mast cells and leukocytes Prostaglandin D2 FPIA Kit - Red (512051) 80% B/B0: 550 pg/ml 60-90 minutes at
by a cellular, myeloid-type, glutathione- OH room temperature
dependent PGD synthase. This PGD2, COOH

which is formed in intracellular and vascular Prostaglandin D2- MOX EIA Kit (512011) 50% B/B0: 15 pg/ml Overnight at 4°C
O
compartments, is rapidly metabolized to OH 80% B/B0: 3.1 pg/ml
11β-PGF2α. Thus, urinary measurements PGD2
of PGD2 synthesis are most appropriately Prostaglandin D2- MOX Express EIA Kit 50% B/B0: 75.2 pg/ml 1 hour at room
focused on the measurement of 11β-PGF2α.
Measurement of the parent eicosanoid
(500151) 80% B/B0: 16 pg/ml temperature
PGD2 is appropriate in the supernatants OH

of cell cultures, where PGD2 levels may COOH

11β-Prostaglandin F2α EIA Kit (516521) 50% B/B0: 32 pg/ml 18 hours at room
reach several ng/ml, and in CSF, where 80% B/B0: 5.5 pg/ml temperature
concentrations of several hundred pg/ml HO
OH
have been measured. 11β-PGF2α tetranor-PGDM EIA Kit (501001) 50% B/B0: 170 pg/ml Overnight at 4°C
80% B/B0: 40 pg/ml

For full information on these products and more, visit www.caymanchem.com 3

Recommendation for which PGD2 Assay to choose
Sample Type PGD2 EIA Kit PGD2 Express EIA Kit PGD2-MOX EIA Kit 11β-Prostaglandin F2α EIA tetranor-PGDM EIA Kit
(512031) (512041) (512011) Kit (516521) (501001)
Plasma/serum X X X  X
Urine

X X X (may not be present 
in mouse urine)
Cell culture
   X X
In vitro PGDS reactions
   X X
CSF X X  X X
BAL, sputum X X  X X
Notes Directly measures PGD2; Directly measures PGD2; Most sensitive kit for Measures the primary plasma Most abundant urinary
methoximation not required methoximation not required measurement of PGD2 metabolic product of PGD2 metabolite of PGD2

X Not recommended recommended matrix

DP Receptor Reagents
PGD2 Synthase
Antibodies Agonists Antagonists
Inhibitors
DP1 Receptor Polyclonal Antibody 101640 Prostaglandin D2 12010 AH 6809 14050 AT-56 13160
BW 245C 12050, MK 0524 10009835 HQL-79 10134
DP1 15(S)-15-methyl Prostaglandin D2 12730 BW A868C 12060
11-keto Fluprostenol 16783
15-deoxy-Δ12,14-Prostaglandin D2 12700

CRTH2/DP2 Receptor (C-Term) Polyclonal Antibody Prostaglandin D2 12010 BAY-u3405 10156

10007002
15(R)-15-methyl Prostaglandin D2 12720 CAY10471 10006735
CRTH2/DP2 Receptor (N-Term) Polyclonal Antibody
10004886 13,14-dihydro-15-keto Prostaglandin D2 12610 CAY10595 10012553

Prostaglandin D Synthase (hematopoietic-type; human) Prostaglandin J2 18500 CAY10597 10012539

Monoclonal Antibody (Clone 2A5) 10004345
15-deoxy-Δ12,14-Prostaglandin J2 18570 OC000459 12027
Prostaglandin D Synthase (hematopoietic-type; mouse)
Monoclonal Antibody (Clone 7H4) 10004349 15-deoxy-Δ12,14-Prostaglandin J2-2-glycerol ester 10010132

Prostaglandin D Synthase (hematopoietic-type) Δ12,14-Prostaglandin J2 18550

Polyclonal Antibody 160013
17-phenyl trinor Prostaglandin D2 12810
Prostaglandin D Synthase (hematopoietic -type; human)
DP2
Polyclonal Antibody 10004337 15-deoxy-Δ12,14-Prostaglandin D2 12700
(CRTH2)
Prostaglandin D Synthase (hematopoietic-type; mouse) Indomethacin 70270
Polyclonal Antiserum 10004348
11-keto Fluprostenol 16783
Prostaglandin D Synthase (lipocalin-type; human) Mono-
clonal Antibody (Clone 10A5) 10004342 11-deoxy-11-methylene-15-keto Prostaglandin D2 12415
Prostaglandin D Synthase (lipocalin-type)
Polyclonal Antibody 160003

Prostaglandin D Synthase (lipocalin-type; mouse)

Polyclonal Antibody 10004344

4 Cayman Chemical • Ann Arbor, MI 48108 • 800.364.9897 • www.caymanchem.com

Prostaglandin E2 PGE2 Pathway Reagents
Receptor Synthase PGE2 Synthase
Agonists Antagonists
Antibodies Antibodies Inhibitors
Prostaglandin E2 (PGE2) is one of the primary arachidonic acid
metabolites via the COX pathway and one of the most widely EP1 EP1 Receptor Prostaglandin E2 AH 6809 Prostaglandin E CAY10526
investigated prostaglandins. Like most eicosanoids, it does not Polyclonal 14010 14050 Synthase-1 10010088
Antibody (microsomal)
exist preformed in any cellular reservoir. When cells are activated or 101740 17-phenyl trinor SC-19220
Polyclonal YS121
exogenous free arachidonate is supplied, PGE2 is synthesized de Prostaglandin E2 14060
Antibody 13665
novo and released into the extracellular space. In vivo, PGE2 is rapidly 14810
ONO-8711 160140
converted to an inactive metabolite (13,14-dihydro-15-keto PGE2) by 14070 CAY10589
17-phenyl trinor
the prostaglandin 15-dehydrogenase pathway. The half-life of PGE2 in 8-iso Prostaglandin E 13164
SC-51089
the circulatory system is approximately 30 seconds and normal plasma Prostaglandin E2 10011561
Synthase-1
levels are 3-12 pg/ml. Because of the rapid metabolism of PGE2, the 10007931 (microsomal)
SC-51322 Monoclonal
determination of in vivo PGE2 biosynthesis is often best accomplished
10010744 Antibody
by the measurement of PGE2 metabolites. PGE2 activity influences
GW 848687X 10004350
inflammation, fertility and parturition, gastric mucosal integrity, and
immune modulation. Because of its involvement in inflammation, PGE2 10010410
Prostaglandin E
is a key indicator of non-steroidal anti-inflammatory drug efficacy via Synthase-2
inhibition of COX-1 and COX-2. EP2 EP2 Receptor Prostaglandin E2 AH 6809
(microsomal)
Polyclonal 14010 14050
Antibody Polyclonal
101750 Butaprost PF-04418948 Antibody
13740,13741 15016 160145
EP2 Receptor 11-deoxy-16,
O COOH Polyclonal 16-dimethyl Prostaglandin E
PE Antibody Prostaglandin E2 Synthase
O 10477 14570 (cytosolic)
Polyclonal
PGH2 OH 19(R)-hydroxy Antibody
Prostaglandin E2 160150
14910
PGE Synthase CAY10408 Prostaglandin
13747 E Synthase
(cytosolic)
O Misoprostol
Monoclonal
13820
COOH Antibody
(Clone JJ6)
HO
18219
OH
EP3 EP3 Receptor Prostaglandin E2 AH 6809 Prostaglandin
PGE2 Polyclonal 14010 14050 E Synthase
Antibody (cytosolic, FL)
15-OH PGDH Sulprostone
101760 Polyclonal
14765 Antibody
O 17-phenyl trinor 10209
Prostaglandin E2
COOH
14810
11-deoxy-16,
HO
O 16-dimethyl
Prostaglandin E2
14570
15-oxoprostaglandin Δ13-reductase 17-phenyl
trinor 8-iso PGE2
O 10007931
Misoprostol
COOH
13820

HO
O EP4 EP4 Receptor Prostaglandin E2 GW627368X
(N-Term) 14010 10009162
13,14-dihydro-15-keto-PGE2 Polyclonal
Antiserum CAY10580 L-161, 982
101770 16835 10011565
Non-enzymatic degradation EP4 Receptor
(C-Term) L-902,688 AH 23848
Polyclonal 10007712 19023
O
Antibody
COOH
101775 CAY10598 MF498
13281 15973
EP4 Receptor
O (C-Term) Misoprostol CJ-42794
Polyclonal 13820 10010428
13,14-dihydro-15-keto-PGA2 PE Antibody
10479
KMN-80 ONO-AE3-208
15435 14522, 16108

For full information on these products and more, visit www.caymanchem.com 5

Product Name (Item No.) Sensitivity · Limit of Detection Incubation Time

Prostaglandin E Metabolite EIA Kit (514531) 50% B/B0: 11 pg/ml • 80% B/B0: 2 pg/ml 18 hours at room temperature

Prostaglandin E2 EIA Kit - Monoclonal (514010) 50% B/B0: 50 pg/ml • 80% B/B0: 15 pg/ml 18 hours at 4°C

Prostaglandin E2 Express EIA Kit (500141) 50% B/B0: 125 pg/ml • 80% B/B0: 36 pg/ml 60 minutes at room temperature

Prostaglandin E2 FPIA Kit - Green (500501) 80% B/B0: 150 pg/ml 60-90 minutes at room temperature

Prostaglandin E2 FPIA Kit - Red (10004517) 80% B/B0: 100 pg/ml 60-90 minutes at room temperature

Recommendation for which PGE2 Assay to choose

Prostaglandin E2 EIA Kit - Prostaglandin E Metabolite
Sample Type Prostaglandin E2 Express EIA Kit (500141)
Monoclonal (514010) EIA Kit (514531)
Plasma X X 
Serum X X 
Urine X X 
Cell culture   X
In vitro COX-2 reactions and
mPGES reactions   N/A
1 hr incubation ~2.5-fold less sensitive than overnight Converts downstream metabolites of
Notes Most sensitive, overnight incubation
format PGE2 to a single stable product

X Not recommended Recommended matrix

Prostaglandin F2a Product Name
(Item No.)
Sensitivity
Limit of Detection
Recommended
Sample Matrices
Incubation
Time
Prostaglandin F2α (PGF2α) is produced from arachidonic acid through Prostaglandin F2α 50% B/B0: 52 pg/ml Cell culture 18 hours at
the enzymatic reduction of PGH2. The conversion to PGF2α has been EIA Kit (516011) 80% B/B0: 9 pg/ml 4°C
shown in many cells including kidney, uterus, and seminal vesicles. The
prominent action of PGF2α is luteolysis, as well as bronchoconstriction
and constriction of the trachea and vascular smooth muscle. Binding 13,14-dihydro- 50% B/B0: 120 pg/ml Plasma, urine 18 hours at
of PGF2α has been demonstrated in a variety of tissues of which, the 15-keto Prosta- 80% B/B0: 13 pg/ml 4°C
corpus luteum shows the highest activity. Like all of the primary PGs, glandin F2α EIA Kit
PGF2α has a very short half-life in the general circulation. The plasma (516671)
concentration of PGF2α in humans is <10 pg/ml, and probably no
more than 1-2 pg/ml. PGF2α is rapidly metabolized by 15-hydroxy PG
dehydrogenase and both β- and ω-oxidation systems to a variety of
polar metabolites including 13,14-dihydro-15-keto PGF2α. In primary PGF2α Analogs as Ocular Hypotensives
cultures, the metabolism of PGF2α is much more limited, and it may
collect in the supernatant medium to easily measured concentrations.
Certain metabolically stable analogs of PGF2α act as highly potent agonists
for the FP receptor. In human and animal models of glaucoma, FP receptor
agonist activity corresponds very closely with intraocular hypotensive
activity. Both 17-phenyl trinor PGF2α ethyl amide, an F-series prostaglandin
O COOH
analog, and Latanoprost, an F-series prostaglandin ester prodrug, have
O been approved for use as ocular hypotensive agents.
PGH2 OH
Product Name Sensitivity Recommended Incubation
(Item No.) Limit of Detection Sample Matrices Time
PGF Synthase
17-phenyl trinor 50% B/B0: 15.5 pg/ml Aqueous humor, tears Overnight at
Prostaglandin F2α 80% B/B0: 2.6 pg/ml 4°C
OH
EIA Kit (516821)
COOH

HO
OH
Latanoprost EIA 50% B/B0: 58 pg/ml Aqueous humor, tears 2 hours
Kit (516811) (free acid) and at room
PGF2α 15-hydroxy PGDH 200 pg/ml (ester) temperature
80% B/B0: 15 pg/ml
15-oxoprostaglandin Δ13-reductase
(free acid) and
OH 43 pg/ml (ester)

COOH
Fluprosten EIA Kit 50% B/B0: 110 pg/ml Aqueous humor, tears Overnight at
(516761) 80% B/B0: 16 pg/ml 4°C
HO
O

13,14-dihydro-15-keto-PGF2α

6 Cayman Chemical • Ann Arbor, MI 48108 • 800.364.9897 • www.caymanchem.com

FP Receptor Reagents
Antibodies/Probes Agonists Antagonists
FP Receptor Polyclonal Antibody Prostaglandin F2α Cloprostenol (sodium salt) AL 8810
101802 16010, 16032, 16033 16764, 16765, 16766, 10006692 16735
16,16-dimethyl Prostaglandin F2α
16-phenoxy tetranor Prostaglandin F2α AL 8810 isopropyl ester
16750
16760 10113
15(S)-15-methyl Prostaglandin F2α
16743 Tafluprost Prostaglandin F2α dimethyl amide
10005440, 10005439 16032
Latanoprost
16812, 16811
Fluprostenol Prostaglandin F2α dimethyl amine
Bimatoprost 16767, 16768, 16769 16033
16820, 16810
CAY10509 10009167
CAY10510 10009168
17-phenoxy trinor Prostaglandin F2α 10010839
15(R)-17-phenyl trinor Prostaglandin F2α 16814

Isoprostanes
The isoprostanes are a family of eicosanoids formed by the random oxidation of tissue phospholipids by oxygen radicals. 8-Isoprostane has been proposed
as a marker of antioxidant deficiency and oxidative stress.

Product Name Sensitivity

Recommended Sample Matrices Incubation Time
(Item No.) Limit of Detection
8-Isoprostane EIA Kit (516351) 50% B/B0: 10 pg/ml Culture media, homogenized tissues, lavage 18 hours at 4°C
80% B/B0: 2.7 pg/ml fluids & aspirates, plasma, urine

8-Isoprostane Express EIA Kit (516360) 50% B/B0: 50 pg/ml Culture media, homogenized tissues, lavage 2 hours at room temperature
80% B/B0: 10 pg/ml fluids & aspirates, plasma, urine

STAT-8-Isoprostane EIA Kit (500431) 50% B/B0: 180 pg/ml Culture media, homogenized tissues, lavage 1 hour at room temperature
80% B/B0: 45 pg/ml fluids & aspirates, plasma, urine

For full information on these products and more, visit www.caymanchem.com 7

 Prostaglandin Screening EIA Kit 514012
Prostaglandin Screening EIA Kit 514012 100 100

Stability: ≥1 year at -20°C

Sensitivity: 50% B/B0: 220 pg/ml • 80% B/B0: 29 pg/ml 80 80

Summary: This assay was developed for screening applications in which the
relative amount of PG production for a large number of cell culture samples must 60 60
be determined. The antiserum used in this assay exhibits high cross reactivity for

%B/B0

%CV
most PGs which will allow quantification of all the PGs in a given sample with a
40 40
single assay.
Specificity:
Prostaglandin E1 100% 20 20

Prostaglandin E2 100%
Prostaglandin F1α 100%
0 0
Prostaglandin F2α 100% 10 100 1,000
Prostaglandin F3α 51.3% Prostaglandin (pg/ml)
For a full specificity profile, please go to www.caymanchem.com
Prostaglandin Standard curve Evaluate data cautiously
96 solid/strip wells Prostaglandin Intra-assay variation
480 solid/strip wells Prostaglandin Inter-assay variation Use data with confidence

Prostaglandin Screening Libraries

Put our expertise to work for you. Discover the Cayman difference!

A collection of Cayman’s extensive, highly purified Prostaglandin Screening Library I (96-well) 10501
prostaglandin compounds conveniently packaged in a This screening plate contains more than 70 “F-series” of prostaglandins and
isoprostanes in a 96-well Matrix tube rack format as 2 mM stocks in DMSO.
ready-to-use format
50 µL
100 µL
• Amenable to high throughput 200 µL

screening Prostaglandin Screening Library II (96-well) 10502

• Cost effective while providing This screening plate contains more than 60 “D and E-series” of prostaglandins
in a 96-well Matrix tube rack format as 2 mM stocks in DMSO.
compound diversity 50 µL
100 µL
• Full disclosure of plate contents 200 µL

Prostaglandin Screening Library III (96-well) 10503

This screening plate contains more than 75 “A and J-series” of prostaglandins
in a 96-well Matrix tube rack format as 2 mM stocks in DMSO.
50 µL
100 µL
200 µL

8 Cayman Chemical • Ann Arbor, MI 48108 • 800.364.9897 • www.caymanchem.com